Literature DB >> 9935150

Elevated expression of eIF4E in confined early breast cancer lesions: possible role of hypoxia.

R J DeFatta1, E A Turbat-Herrera, B D Li, W Anderson, A De Benedetti.   

Abstract

The translation-initiation factor eIF4E is rate-limiting for protein synthesis, and its over-expression results in oncogenic transformation of mammalian cells. eIF4E facilitates the synthesis of several powerful tumor angiogenic factors (FGF-2 and VEGF) by selectively enhancing their translation. In breast carcinomas, eIF4E is commonly over-expressed, but the pathology where this elevation is initially manifested is presently unknown. To probe whether the elevation of eIF4E marks an early stage of cancer development, we focused our research on early cancerous lesions. We have analyzed 70 invasive ductal carcinomas (IDCs), 78 ductal carcinomas in situ (DCIS), 51 benign lesions and 4 model cell lines for elevated expression of eIF4E by several different methods: Northern/Western blots, immuno-histochemistry and in situ RT-PCR. eIF4E expression was markedly increased in IDC and in islets of viable cells in the center of poorly vascularized DCIS, which are not easily identifiable by standard histological stains. We also show that expression of eIF4E is increased by hypoxia and, presumably, in hypoxic areas of these lesions. We propose that clonal expansion of cancer cells, permanently over-expressing eIF4E, gives them a critical advantage to survive hypoxia and marks the transition toward the vascular phase of cancer progression. Hence, eIF4E may be useful in stratifying DCIS lesions according to their malignant stage.

Entities:  

Mesh:

Substances:

Year:  1999        PMID: 9935150     DOI: 10.1002/(sici)1097-0215(19990209)80:4<516::aid-ijc6>3.0.co;2-7

Source DB:  PubMed          Journal:  Int J Cancer        ISSN: 0020-7136            Impact factor:   7.396


  14 in total

Review 1.  Genome-wide analysis of microRNA and mRNA expression signatures in cancer.

Authors:  Ming-hui Li; Sheng-bo Fu; Hua-sheng Xiao
Journal:  Acta Pharmacol Sin       Date:  2015-08-24       Impact factor: 6.150

2.  Among translational effectors, p70S6k is uniquely sensitive to inhibition by glucocorticoids.

Authors:  O J Shah; S R Kimball; L S Jefferson
Journal:  Biochem J       Date:  2000-04-15       Impact factor: 3.857

3.  Expression of eukaryotic initiation factor 4E and 4E binding protein 1 in colorectal carcinogenesis.

Authors:  Mona Diab-Assaf; Raefa Abou-Khouzam; Nina Saadallah-Zeidan; Khaled Habib; Nizar Bitar; Walid Karam; Bertrand Liagre; Steve Harakeh; Rania Azar
Journal:  Int J Clin Exp Pathol       Date:  2015-01-01

Review 4.  The biological and therapeutic relevance of mRNA translation in cancer.

Authors:  Sarah P Blagden; Anne E Willis
Journal:  Nat Rev Clin Oncol       Date:  2011-03-01       Impact factor: 66.675

5.  Eukaryotic Translation Initiation Factor 4E Is a Feed-Forward Translational Coactivator of Transforming Growth Factor β Early Protransforming Events in Breast Epithelial Cells.

Authors:  Lindsey Decarlo; Celine Mestel; Mary-Helen Barcellos-Hoff; Robert J Schneider
Journal:  Mol Cell Biol       Date:  2015-05-18       Impact factor: 4.272

6.  Design, synthesis and evaluation of analogs of initiation factor 4E (eIF4E) cap-binding antagonist Bn7-GMP.

Authors:  Yan Jia; Ting-Lan Chiu; Elizabeth A Amin; Vitaly Polunovsky; Peter B Bitterman; Carston R Wagner
Journal:  Eur J Med Chem       Date:  2009-12-06       Impact factor: 6.514

7.  Cancer-specific targeting of a conditionally replicative adenovirus using mRNA translational control.

Authors:  Mariam A Stoff-Khalili; Angel A Rivera; Ana Nedeljkovic-Kurepa; Arrigo DeBenedetti; Xiao-Lin Li; Yoshinobu Odaka; Jagat Podduturi; Don A Sibley; Gene P Siegal; Alexander Stoff; Scott Young; Zheng B Zhu; David T Curiel; J Michael Mathis
Journal:  Breast Cancer Res Treat       Date:  2007-05-17       Impact factor: 4.872

8.  Asthma and COPD - The C/EBP Connection.

Authors:  Nicola Miglino; Michael Roth; Michael Tamm; Peter Borger
Journal:  Open Respir Med J       Date:  2012-04-20

9.  Tissue microarray analysis of eIF4E and its downstream effector proteins in human breast cancer.

Authors:  Heather E Kleiner; Prasad Krishnan; Jesse Tubbs; Mark Smith; Carol Meschonat; Runhua Shi; Mary Lowery-Nordberg; Patrick Adegboyega; Marcia Unger; James Cardelli; Quyen Chu; J Michael Mathis; John Clifford; Arrigo De Benedetti; Benjamin D L Li
Journal:  J Exp Clin Cancer Res       Date:  2009-01-09

10.  Understanding and Targeting the Eukaryotic Translation Initiation Factor eIF4E in Head and Neck Cancer.

Authors:  Biljana Culjkovic; Katherine L Borden
Journal:  J Oncol       Date:  2009-12-13       Impact factor: 4.375

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.